AA
DMAA

AQR Arbitrage’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

AQR Arbitrage’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75M Sell
357,585
-13,626
-4% -$142K 0.06% 274
2025
Q4 		$3.85M Hold
371,211
– – 0.08% 235
2025
Q3 		$3.81M Sell
371,211
-5,103
-1% -$52.4K 0.1% 209
2025
Q2 		$3.84M Sell
376,314
-4,000
-1% -$40.5K 0.09% 183
2025
Q1 		$3.81M Buy
+380,314
New +$3.8M 0.09% 179

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.22% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Arbitrage's DMAA Position: Q1 2026 in Review

AQR Arbitrage reduced its Drugs Made In America Acquisition Corp (DMAA) stake by 3.7% in Q1 2026, selling an estimated $142K and leaving 357,585 shares worth $3.75M. The position accounts for 0.06% of the portfolio, ranked #274.

AQR Arbitrage first reported a position in DMAA in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.85M in Q4 2025. 39 funds tracked by Wall St. Rank hold DMAA as of Q1 2026.

  • AQR Arbitrage held 357,585 shares of Drugs Made In America Acquisition Corp worth $3.75M as of Q1 2026.
  • AQR Arbitrage sold 13,626 Drugs Made In America Acquisition Corp shares in Q1 2026, an estimated $142K.
  • Drugs Made In America Acquisition Corp made up 0.06% of AQR Arbitrage's portfolio in Q1 2026, its #274 holding.
  • AQR Arbitrage first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • AQR Arbitrage's Drugs Made In America Acquisition Corp position peaked at $3.85M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.